Upcoming Brussels meet between India, EU to look at the ban on around 700 pharma products which were clinically tested by Hyderabad-based G...

GVK Biosciences was under the regulatory scanner of European drug regulators a few months ago.

This is the first pact the city-based clinical research the company has inked after it got involved in regulatory issues with European Medi...

The German watchdog said it will take a decision shortly on whether to add more medicines to the list of banned drugs in the wake of the EM...

Medicines affected by the suspension of marketing authorisation will be allowed to resume sales if the companies furnish fresh clinical tri...

The regulator said it had informed the drugs manufacturers about its decision on Monday and the ban on the sales of medicines came into eff...

European Medicines Agency (EMA) said in a statement that it is reviewing findings of non-compliance with good clinical practise at the GVK ...

Vanta Bio is into offering toxicology evaluation services for pharmaceutical, biotech, food supplements and feed additives industries.

The review of medicines for which studies have been conducted by GVK Bio has been initiated at the request of the European Commission.

GVK Biosciences (GVK BIO), which unveiled a new brand, today said it aims to be among the top three clinical research organisations in Asia...

GVK Biosciences proposes to set up active pharmaceutical ingredients (APIs) manufacturing facility to cater to the needs of its existing an...

GVK BIO, a leading small-molecule Contract Research Organisation (CRO) today announced that it signed an agreement to acquire Aragen Biosci...

The Hyderabad-based firm and Onconova have entered into a JV to develop new drugs for cancer, GVK Biosciences said in a statement.

The joint partnership will be based in the US and will align research priorities and tech expertise from both companies.

The company's Ahmedabad Clinical Pharmacology Unit successfully cleared US Food and Drug Administration audit with zero 483s/observations f...

Drug discovery research and development organisation GVK Biosciences has been selected as a preferred provider to a consortium of 14 global...

Premier contract research company GVK Bioscience on Thursday appointed Manni Kantipudi, former chief information officer of Intel corporati...